These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 11672756

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. alpha(2A)-adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels.
    Keularts IM, van Gorp RM, Feijge MA, Vuist WM, Heemskerk JW.
    J Biol Chem; 2000 Jan 21; 275(3):1763-72. PubMed ID: 10636873
    [Abstract] [Full Text] [Related]

  • 23. Reciprocal cross-talk between P2Y1 and P2Y12 receptors at the level of calcium signaling in human platelets.
    Hardy AR, Jones ML, Mundell SJ, Poole AW.
    Blood; 2004 Sep 15; 104(6):1745-52. PubMed ID: 15187029
    [Abstract] [Full Text] [Related]

  • 24. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
    Aslam M, Sedding D, Koshty A, Santoso S, Schulz R, Hamm C, Gündüz D.
    Thromb Res; 2013 Nov 15; 132(5):548-57. PubMed ID: 24071464
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist.
    Baurand A, Raboisson P, Freund M, Léon C, Cazenave JP, Bourguignon JJ, Gachet C.
    Eur J Pharmacol; 2001 Feb 02; 412(3):213-21. PubMed ID: 11166284
    [Abstract] [Full Text] [Related]

  • 26. Alpha-adrenergic stimulation of phosphatidylinositol synthesis in human platelets as an alpha-2 effect secondary to platelet aggregation.
    Wallace MA, Agarwal KC, Garcia-Sainz JA, Fain JN.
    J Cell Biochem; 1982 Feb 02; 18(2):213-20. PubMed ID: 6121823
    [Abstract] [Full Text] [Related]

  • 27. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.
    Foster CJ, Prosser DM, Agans JM, Zhai Y, Smith MD, Lachowicz JE, Zhang FL, Gustafson E, Monsma FJ, Wiekowski MT, Abbondanzo SJ, Cook DN, Bayne ML, Lira SA, Chintala MS.
    J Clin Invest; 2001 Jun 02; 107(12):1591-8. PubMed ID: 11413167
    [Abstract] [Full Text] [Related]

  • 28. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.
    Storey RF, Sanderson HM, White AE, May JA, Cameron KE, Heptinstall S.
    Br J Haematol; 2000 Sep 02; 110(4):925-34. PubMed ID: 11054084
    [Abstract] [Full Text] [Related]

  • 29. Effects of imidazoline and non-imidazoline α-adrenergic agents on rabbit platelet aggregation.
    Yokota S, Hikasa Y, Mizushima H.
    Pharmacology; 2013 Sep 02; 91(3-4):135-44. PubMed ID: 23364471
    [Abstract] [Full Text] [Related]

  • 30. Activation of Rap1B by G(i) family members in platelets.
    Woulfe D, Jiang H, Mortensen R, Yang J, Brass LF.
    J Biol Chem; 2002 Jun 28; 277(26):23382-90. PubMed ID: 11970953
    [Abstract] [Full Text] [Related]

  • 31. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ, Leis LA, Francis GS.
    Circulation; 1986 Apr 28; 73(4):847-54. PubMed ID: 3004784
    [Abstract] [Full Text] [Related]

  • 32. Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets.
    Clare KA, Scrutton MC, Thompson NT.
    Br J Pharmacol; 1984 Jun 28; 82(2):467-76. PubMed ID: 6145472
    [Abstract] [Full Text] [Related]

  • 33. Platelet ADP receptor and alpha 2-adrenoreceptor interaction. Evidence for an ADP requirement for epinephrine-induced platelet activation and an influence of epinephrine on ADP binding.
    Figures WR, Scearce LM, Wachtfogel Y, Chen J, Colman RF, Colman RW.
    J Biol Chem; 1986 May 05; 261(13):5981-6. PubMed ID: 3009439
    [Abstract] [Full Text] [Related]

  • 34. Effects of imidazoline and non-imidazoline alpha-adrenergic agents on canine platelet aggregation.
    Hikasa Y, Abe M, Satoh T, Hisashi Y, Ogasawara S, Matsuda H.
    Pharmacology; 1999 Apr 05; 58(4):171-82. PubMed ID: 10077736
    [Abstract] [Full Text] [Related]

  • 35. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
    Puri RN, Colman RF, Colman RW.
    Eur J Biochem; 1996 Mar 15; 236(3):862-70. PubMed ID: 8665907
    [Abstract] [Full Text] [Related]

  • 36. Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270.
    Ding Z, Kim S, Dorsam RT, Jin J, Kunapuli SP.
    Blood; 2003 May 15; 101(10):3908-14. PubMed ID: 12560222
    [Abstract] [Full Text] [Related]

  • 37. Effects of a P2Y(12) receptor antagonist on the response of equine platelets to ADP. Comparison with human platelets.
    Mateos-Trigos G, Evans RJ, Heath MF.
    Res Vet Sci; 2002 Oct 15; 73(2):171-5. PubMed ID: 12204637
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.